{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T22:31:50Z","timestamp":1778106710386,"version":"3.51.4"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1124\/molpharm.120.000108","type":"journal-article","created":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T16:25:13Z","timestamp":1609431913000},"page":"175-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Short-Term Acyl-CoA:Cholesterol Acyltransferase Inhibition, Combined with Apoprotein A1 Overexpression, Promotes Atherosclerosis Inflammation Resolution in Mice"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6077-3545","authenticated-orcid":false,"given":"Jaume","family":"Amengual","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoscar","family":"Ogando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyrus","family":"Nikain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Quezada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Vaisar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward A.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/molpharm.120.000108_bib1","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1172\/JCI9021","article-title":"Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1","volume":"105","author":"Accad","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1124\/molpharm.120.000108_bib2","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1194\/jlr.M700274-JLR200","article-title":"The roles of different pathways in the release of cholesterol from macrophages","volume":"48","author":"Adorni","year":"2007","journal-title":"J Lipid Res"},{"key":"10.1124\/molpharm.120.000108_bib3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/MOL.0000000000000634","article-title":"Monocytes and macrophages in atherogenesis","volume":"30","author":"Amengual","year":"2019","journal-title":"Curr Opin Lipidol"},{"key":"10.1124\/molpharm.120.000108_bib4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1254\/jjp.76.309","volume":"76","author":"Aragane","year":"1998","journal-title":"Jpn J Pharmacol"},{"issue":"Suppl","key":"10.1124\/molpharm.120.000108_bib5","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1194\/jlr.R800044-JLR200","article-title":"The ABCs of sterol transport","volume":"50","author":"Bald\u00e1n","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1124\/molpharm.120.000108_bib6","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/CIRCULATIONAHA.119.039476","article-title":"Apolipoprotein AI) promotes atherosclerosis regression in diabetic mice by suppressing myelopoiesis and plaque inflammation","volume":"140","author":"Barrett","year":"2019","journal-title":"Circulation"},{"key":"10.1124\/molpharm.120.000108_bib7","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1194\/jlr.M059865","article-title":"HDL-apolipoprotein A-I exchange is independently associated with cholesterol efflux capacity","volume":"56","author":"Borja","year":"2015","journal-title":"J Lipid Res"},{"key":"10.1124\/molpharm.120.000108_bib8","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.90926.2008","article-title":"Acyl-coenzyme A:cholesterol acyltransferases","volume":"297","author":"Chang","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1124\/molpharm.120.000108_bib9","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1161\/CIRCULATIONAHA.108.841130","article-title":"ATP-binding cassette transporter A1 expression and apolipoprotein A-I binding are impaired in intima-type arterial smooth muscle cells","volume":"119","author":"Choi","year":"2009","journal-title":"Circulation"},{"key":"10.1124\/molpharm.120.000108_bib10","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1161\/01.ATV.0000142808.34602.25","article-title":"High-density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidation","volume":"24","author":"Choudhury","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/molpharm.120.000108_bib11","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1161\/ATVBAHA.118.307026","article-title":"Translating evidence of HDL and plaque regression","volume":"38","author":"Di Bartolo","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/molpharm.120.000108_bib12","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"10.1124\/molpharm.120.000108_bib13","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMe068012","article-title":"Failure of ACAT inhibition to retard atherosclerosis","volume":"354","author":"Fazio","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1124\/molpharm.120.000108_bib14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1172\/JCI10310","article-title":"Increased atherosclerosis in LDL receptor-null mice lacking ACAT1 in macrophages","volume":"107","author":"Fazio","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1124\/molpharm.120.000108_bib15","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1161\/CIRCULATIONAHA.110.984146","article-title":"Reversal of hyperlipidemia with a genetic switch favorably affects the content and inflammatory state of macrophages in atherosclerotic plaques","volume":"123","author":"Feig","year":"2011","journal-title":"Circulation"},{"key":"10.1124\/molpharm.120.000108_bib16","doi-asserted-by":"crossref","first-page":"7166","DOI":"10.1073\/pnas.1016086108","article-title":"HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells","volume":"108","author":"Feig","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/molpharm.120.000108_bib17","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/ncb1035","article-title":"The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages","volume":"5","author":"Feng","year":"2003","journal-title":"Nat Cell Biol"},{"key":"10.1124\/molpharm.120.000108_bib18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s11926-012-0313-z","article-title":"Cholesterol crystals and inflammation","volume":"15","author":"Grebe","year":"2013","journal-title":"Curr Rheumatol Rep"},{"key":"10.1124\/molpharm.120.000108_bib19","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/ATVBAHA.113.303044","article-title":"Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in mice","volume":"34","author":"Hewing","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/molpharm.120.000108_bib20","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1373\/clinchem.2014.228114","article-title":"Quantification of HDL particle concentration by calibrated ion mobility analysis","volume":"60","author":"Hutchins","year":"2014","journal-title":"Clin Chem"},{"key":"10.1124\/molpharm.120.000108_bib21","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.134796","article-title":"Neutrophil extracellular traps promote macrophage inflammation and impair atherosclerosis resolution in diabetic mice","volume":"5","author":"Josefs","year":"2020","journal-title":"JCI Insight"},{"key":"10.1124\/molpharm.120.000108_bib22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1254\/jjp.69.53","article-title":"Hypocholesterolemic action and prevention of cholesterol absorption via the gut by F-1394, a potent acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor, in cholesterol diet-fed rats","volume":"69","author":"Kusunoki","year":"1995","journal-title":"Jpn J Pharmacol"},{"key":"10.1124\/molpharm.120.000108_bib23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1254\/jjp.67.195","article-title":"Studies on acyl-CoA: cholesterol acyltransferase (ACAT) inhibitory effects and enzyme selectivity of F-1394, a pantotheic acid derivative","volume":"67","author":"Kusunoki","year":"1995","journal-title":"Jpn J Pharmacol"},{"key":"10.1124\/molpharm.120.000108_bib24","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1161\/01.CIR.103.21.2604","article-title":"Acyl-CoA:cholesterol acyltransferase inhibition reduces atherosclerosis in apolipoprotein E-deficient mice","volume":"103","author":"Kusunoki","year":"2001","journal-title":"Circulation"},{"key":"10.1124\/molpharm.120.000108_bib25","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/S0022-2275(20)32360-9","article-title":"Differential expression of ACAT1 and ACAT2 among cells within liver, intestine, kidney, and adrenal of nonhuman primates","volume":"41","author":"Lee","year":"2000","journal-title":"J Lipid Res"},{"key":"10.1124\/molpharm.120.000108_bib26","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/nm1102-1257","article-title":"Stabilization of atherosclerotic plaques: new mechanisms and clinical targets","volume":"8","author":"Libby","year":"2002","journal-title":"Nat Med"},{"key":"10.1124\/molpharm.120.000108_bib27","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1091\/mbc.E15-10-0730","article-title":"Acute accumulation of free cholesterol induces the degradation of perilipin 2 and Rab18-dependent fusion of ER and lipid droplets in cultured human hepatocytes","volume":"27","author":"Makino","year":"2016","journal-title":"Mol Biol Cell"},{"key":"10.1124\/molpharm.120.000108_bib28","doi-asserted-by":"crossref","first-page":"15836","DOI":"10.1074\/jbc.RA119.010564","article-title":"Myeloid Acat1\/Soat1 KO attenuates pro-inflammatory responses in macrophages and protects against atherosclerosis in a model of advanced lesions","volume":"294","author":"Melton","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1124\/molpharm.120.000108_bib29","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1038\/s41467-018-04447-7","article-title":"Integrin beta3 regulates clonality and fate of smooth muscle-derived atherosclerotic plaque cells","volume":"9","author":"Misra","year":"2018","journal-title":"Nat Commun"},{"key":"10.1124\/molpharm.120.000108_bib30","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/j.jacc.2018.08.2147","article-title":"Macrophage trafficking, inflammatory resolution, and genomics in atherosclerosis: JACC macrophage in CVD series (Part 2)","volume":"72","author":"Moore","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/molpharm.120.000108_bib31","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nri3520","article-title":"Macrophages in atherosclerosis: a dynamic balance","volume":"13","author":"Moore","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1124\/molpharm.120.000108_bib32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/01.ATV.14.1.133","article-title":"ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree","volume":"14","author":"Nakashima","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"10.1124\/molpharm.120.000108_bib33","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJMoa054699","article-title":"Effect of ACAT inhibition on the progression of coronary atherosclerosis","volume":"354","author":"Nissen","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1124\/molpharm.120.000108_bib34","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.2337\/db10-0778","article-title":"Diabetes adversely affects macrophages during atherosclerotic plaque regression in mice","volume":"60","author":"Parathath","year":"2011","journal-title":"Diabetes"},{"key":"10.1124\/molpharm.120.000108_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173975","article-title":"A wild-type mouse-based model for the regression of inflammation in atherosclerosis","volume":"12","author":"Peled","year":"2017","journal-title":"PLoS One"},{"key":"10.1124\/molpharm.120.000108_bib36","doi-asserted-by":"crossref","first-page":"9607","DOI":"10.1073\/pnas.91.20.9607","article-title":"Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse","volume":"91","author":"Plump","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/molpharm.120.000108_bib37","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fcvm.2018.00032","article-title":"Insights from pre-clinical and clinical studies on the role of innate inflammation in atherosclerosis regression","volume":"5","author":"Rahman","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"10.1124\/molpharm.120.000108_bib38","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1124\/molpharm.120.000108_bib39","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009778","article-title":"Eradicating the burden of atherosclerotic cardiovascular disease by lowering apolipoprotein B lipoproteins earlier in life","volume":"7","author":"Robinson","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1124\/molpharm.120.000108_bib40","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/ATVBAHA.112.252056","article-title":"ACAT inhibition reduces the progression of preexisting, advanced atherosclerotic mouse lesions without plaque or systemic toxicity","volume":"33","author":"Rong","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/molpharm.120.000108_bib41","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1161\/01.ATV.0000148202.49842.3b","article-title":"Acyl-coenzymeA (CoA):cholesterol acyltransferase inhibition in rat and human aortic smooth muscle cells is nontoxic and retards foam cell formation","volume":"25","author":"Rong","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/molpharm.120.000108_bib42","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1161\/hc4501.098952","article-title":"Elevating high-density lipoprotein cholesterol in apolipoprotein E-deficient mice remodels advanced atherosclerotic lesions by decreasing macrophage and increasing smooth muscle cell content","volume":"104","author":"Rong","year":"2001","journal-title":"Circulation"},{"key":"10.1124\/molpharm.120.000108_bib43","doi-asserted-by":"crossref","first-page":"13531","DOI":"10.1073\/pnas.1735526100","article-title":"Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading","volume":"100","author":"Rong","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/molpharm.120.000108_bib44","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/353265a0","article-title":"Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI","volume":"353","author":"Rubin","year":"1991","journal-title":"Nature"},{"key":"10.1124\/molpharm.120.000108_bib45","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1161\/hc2501.092494","article-title":"High-dose recombinant apolipoprotein A-I(milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization","volume":"103","author":"Shah","year":"2001","journal-title":"Circulation"},{"key":"10.1124\/molpharm.120.000108_bib46","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/cvr\/cvv241","article-title":"Enhanced atheroprotection and lesion remodelling by targeting the foam cell and increasing plasma cholesterol acceptors","volume":"109","author":"Son","year":"2016","journal-title":"Cardiovasc Res"},{"key":"10.1124\/molpharm.120.000108_bib47","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.CIR.92.5.1355","article-title":"A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association","volume":"92","author":"Stary","year":"1995","journal-title":"Circulation"},{"key":"10.1124\/molpharm.120.000108_bib48","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1161\/01.CIR.100.17.1816","article-title":"Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice","volume":"100","author":"Tangirala","year":"1999","journal-title":"Circulation"},{"key":"10.1124\/molpharm.120.000108_bib49","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1161\/01.CIR.0000147777.12010.EF","article-title":"Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions","volume":"110","author":"Tardif","year":"2004","journal-title":"Circulation"},{"key":"10.1124\/molpharm.120.000108_bib50","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2337\/dc19-0772","article-title":"High concentration of medium-sized HDL particles and enrichment in HDL paraoxonase 1 associate with protection from vascular complications in people with long-standing type 1 diabetes","volume":"43","author":"Vaisar","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1124\/molpharm.120.000108_bib51","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1161\/CIRCRESAHA.114.300738","article-title":"ATP-binding cassette transporters, atherosclerosis, and inflammation","volume":"114","author":"Westerterp","year":"2014","journal-title":"Circ Res"},{"key":"10.1124\/molpharm.120.000108_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201700313","article-title":"Targeted nanotherapeutics encapsulating liver X receptor agonist GW3965 enhance antiatherogenic effects without adverse effects on hepatic lipid metabolism in Ldlr-\/- mice","volume":"6","author":"Yu","year":"2017","journal-title":"Adv Healthc Mater"},{"key":"10.1124\/molpharm.120.000108_bib53","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1126\/science.1189731","article-title":"ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation","volume":"328","author":"Yvan-Charvet","year":"2010","journal-title":"Science"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24011015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24011015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/molpharm.120.000108","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:36:15Z","timestamp":1739961375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24011015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0026895X24011015"],"URL":"https:\/\/doi.org\/10.1124\/molpharm.120.000108","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short-Term Acyl-CoA:Cholesterol Acyltransferase Inhibition, Combined with Apoprotein A1 Overexpression, Promotes Atherosclerosis Inflammation Resolution in Mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/molpharm.120.000108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}